Community health workers step in to boost palliative care for black cancer patients
NCT ID NCT05407844
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study tests whether adding a trained community health worker (CHW) to standard care can improve quality of life and advance care planning for African American patients with advanced cancer. 160 patients will either receive standard care or standard care plus CHW support. The CHW helps with communication, understanding palliative care, and addressing social needs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Community health worker (CHW) support
- What this could lead to
- If it works, this could show that trained community health workers help African American patients with advanced cancer feel better and plan their care more effectively.
- What could go wrong
- This is a small, early-stage study (160 participants) focused on a specific group, so results may not apply broadly. The intervention is supportive, not a treatment for cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 160 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2023
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patient Inclusion Criteria: * Self-identified African American patients with advanced (AJCC stage III or IV) solid organ malignancy * \>=18 years old * English speaking * Intact cognition and ability to provide informed consent Patient Exclusion Criteria: * Participants \< 18 years of age * Participants who are already receiving palliative care services Caregiver Inclusion Criteria: * Adult (\>=18 years old) caregivers providing informal (unpaid) care to an eligible African American cancer patient (related or unrelated) * English speaking * Intact cognition and ability to provide informed consent Caregiver Exclusion Criteria: * Participants \< 18 years of age
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
-
TidalHealth Peninsula Regional, Inc.
Salisbury, Maryland, 21801, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Can a video game teach cancer patients to tame their pain?
- Blood thinner flush could boost tumor biopsy success